A controversial impending clinical trial on puberty blocking drugs in Britain will begin on Saturday to recruit hundreds of children as young as 11-years-old.
The so-called “Pathways” trial being run by King’s College London (KCL) will start recruiting some 226 children between the ages of 11 and 16 on August 1st as it seeks to determine the benefits or risks of puberty blockers on supposedly transgender children, the BBC reported.
In 2024, a review from paediatrician Dr Hilary Cass found that previous justification for the use of such hormone-altering therapies in children was “built on shaky foundations” and thus the National Health Service (NHS) should not proscribe them.
Yet, Dr...
Read the full article here